Brief: Kane Biotech Receives Offer For Its Interest In Stem Animal Health
20/12/2023 13:32
Dec 20 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH RECEIVES OFFER FOR ITS INTEREST IN STEM
ANIMAL
HEALTH
* KANE BIOTECH INC: TERMS OF OFFER REMAIN CONFIDENTIAL
* KANE BIOTECH INC: SIGNED A NON-BINDING OFFER FOR SALE OF
ITS
INTEREST IN STEM ANIMAL HEALTH INC
Source text for Eikon: ID:nGNX7LhbdG
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update